Co-morbid biomarkers for sarcopenic obesity associated with gut microbiota metabolites: From burden to treatment
PLOS Computational Biology · 04.05.2026 · 22 (5) · e1014225
DOI: 10.1371/journal.pcbi.1014225 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 04.05.2026. Verfasst von Juehan Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Physical Medicine and Rehabilitation, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Obesity, Gastrointestinal Microbiome, Sarcopenia. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, Natural Science Foundation of Zhejiang Province, the Zhejiang Key Laboratory of Intelligent Rehabilitation and Translational Neuroelectronics.
Abstract (Originalsprache)
Background
The detrimental cycle of sarcopenic obesity (SO) significantly reduces quality of life in older adults, while the mechanisms are still unclear. Materials and methods We first analyzed the incidence of SO using the CHARLS database. We identified key genes by integrating differentially expressed genes, weighted gene co-expression network analysis, and targets of gut microbiota metabolites, refining the selection through machine learning methods (LASSO, XGBoost, SVM-REF, Random Forest). These genes were validated through single-cell sequencing, receiver operating characteristic analysis, and Muscle immunohistochemistry in a high-fat-diet (HFD) induced mouse model. Further analyses comprised immune infiltration profiling, pathway enrichment, and transcriptional regulation analysis. Additionally, we explored the relationships between key genes and autophagy, ferroptosis, and immunity responses. Finally, we predicted and evaluated potential therapeutic compounds via the CMap database and molecular docking.
Results
SO incidence in China increased significantly from 16.1% (2011) to 20.4% (2018). Machine learning identified ALDH1A3, CSF1R, and PHGDH as key genes. These genes were validated in external muscle single-cell datasets, demonstrating robust diagnostic performance with AUC values exceeding 0.72 across four independent GEO cohorts. Following an HFD intervention in mice, ALDH1A3 and CSF1R expression in muscle tissue was significantly upregulated, while PHGDH showed a consistent upward trend that did not reach statistical significance. Immune infiltration analysis revealed a significant increase in resting NK cells in both obesity and sarcopenia states. Functional enrichment analyses using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes linked the genes to transcriptional regulation pathways. The Cisbp_M4923 motif was identified as the most relevant transcription factor binding site. Finally, molecular docking simulations indicated stable binding of the top candidate compound, Birinapant, to the key gene targets.
Conclusion
ALDH1A3, CSF1R, and PHGDH serve as potential co-morbid biomarkers for SO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Physical Medicine and Rehabilitation, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China.
- Department of Critical Care Medicine, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China.
- Emergency and trauma center, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China.
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhe…
- Jinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
- Zhejiang Key Laboratory of Intelligent Rehabilitation and Translational Neuroelectronics, Hangzhou, China.
ORCID-Profile: Zuobing Chen
Förderung
- the National Key Research and Development Program of China
- Natural Science Foundation of Zhejiang Province
- the Zhejiang Key Laboratory of Intelligent Rehabilitation and Translational Neuroelectronics
Zitieren
APA
Wang, J., Li, H., Shi, W., Ren, X., Liu, Y., Mao, L., Wang, D., Zhang, T., Zhang, Z., Zheng, H., Yang, X., Yao, M., & Chen, Z. (2026). Co-morbid biomarkers for sarcopenic obesity associated with gut microbiota metabolites: From burden to treatment. PLOS Computational Biology, 22(5), e1014225. https://doi.org/10.1371/journal.pcbi.1014225
Vancouver
Wang J, Li H, Shi W, Ren X, Liu Y, Mao L, et al. Co-morbid biomarkers for sarcopenic obesity associated with gut microbiota metabolites: From burden to treatment. PLOS Computational Biology. 2026;22(5):e1014225. doi:10.1371/journal.pcbi.1014225
BibTeX
@article{Wang2026,
author = {Wang, Juehan and Li, Haijun and Shi, Weiyi and Ren, Xiaoxu and Liu, Yingying and Mao, Lin and Wang, Daming and Zhang, Tianfang and Zhang, Ziwei and Zheng, Huiqin and Yang, Xiaofeng and Yao, Mingfei and Chen, Zuobing},
title = {Co-morbid biomarkers for sarcopenic obesity associated with gut microbiota metabolites: From burden to treatment},
journal = {PLOS Computational Biology},
year = {2026},
volume = {22},
number = {5},
pages = {e1014225},
doi = {10.1371/journal.pcbi.1014225}
}
EUVIMED